Indianapolis Star report on Lilly/Caremark letters

Doctors noted their dissatisfaction with a direct mail marketing arrangement between Eli Lilly and CVS Caremark in an Indianapolis Star report.

The consternation relates to direct mail communications that are "designed to look like an important letter for a treatment for my patients, not what it really was -- a paid promotion by a drug maker," Dr. Daniel Carlat, a Massachusetts psychiatrist identified in the article as a "well-known critic of drug marketing," told the Star.

At issue as well: the appropriateness of the relationship between drug manufacturer Lilly and pharmacy CVS Caremark.

You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Direct Line Blog

Sign up to our newsletters

Latest Jobs:


Company of the Week


SK&A is a leading provider of U.S. healthcare information solutions and databases. As part of IMS Health, SK&A researches and maintains contact and profiling data for over 2 million healthcare providers, including 800,000+ prescribers. SK&A's data supports research and marketing initiatives for life sciences, medical device, managed healthcare, direct marketing, publishing, education and more. SK&A's proprietary databases are telephone-verified twice per year from its world class Research Centers. SK&A enables multi-channel marketing and sets the standard for data quality and reliability. SK&A's customers include many of America's most recognized healthcare, publishing and pharmaceutical institutions.


Featured Listings

SKA

SKA

SK&A is a leading provider of U.S. healthcare information solutions and databases. As ...